Top

Current Cardiology Reports

Published in:

01-11-2018 | Valvular Heart Disease (TL Kiefer, Section Editor)

Role of Cardiac Magnetic Resonance Imaging in Valvular Heart Disease: Diagnosis, Assessment, and Management

Authors: Roshin C. Mathew, Adrián I. Löffler, Michael Salerno

Published in: Current Cardiology Reports | Issue 11/2018

Abstract

Purpose of Review

This article will review the current techniques in cardiac magnetic resonance imaging (CMR) for diagnosing and assessing primary valvular heart disease.

Recent Findings

The recent advancements in CMR have led to an increased role of this modality for qualifying and quantifying various native valve diseases. Phase-contrast velocity encoded imaging is a well-established technique that can be used to quantify aortic and pulmonic flow. This technique, combined with the improved ability for CMR to obtain accurate left and right ventricular volumetrics, has allowed for increased accuracy and reproducibility in assessing valvular dysfunction. Advancements in CMR technology also allows for improved spatial and temporal resolution imaging of various valves and their regurgitant or stenotic jets. Therefore, CMR can be a powerful tool in evaluation of native valvular heart disease.

Summary

The role of CMR in assessing valvular heart disease is growing and being recognized in recent guidelines. CMR has the ability to assess valve morphology along with qualifying and quantifying valvular disease. In addition, the ability to obtain accurate volumetric measurements may improve more precise management strategies and may lead to improvements in mortality and morbidity.

Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005–11. https://doi.org/10.1016/S0140-6736(06)69208-8.CrossRefPubMed

•• Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, et al. Recommendations for noninvasive evaluation of native valvular regurgitation a report from the American Society of Echocardiography developed in collaboration with the society for cardiovascular magnetic resonance. JASE. 2017;30(4):303–71. https://doi.org/10.1016/j.echo.2017.01.007. Defines the current recommendations for the qualitative and quantitative assessment of for native valve regurgitation by CMR and echo. CrossRef

Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg. 2014;148:e1–132. https://doi.org/10.1016/j.jtcvs.2014.05.014.CrossRefPubMed

Hundley WG, Bluemke DA, Finn JP, Flamm SD, Fogel MA, Friedrich MG, et al. ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol. 2010;55:2614–62. https://doi.org/10.1016/j.jacc.2009.11.011.CrossRefPubMed

Sommer G, Bremerich J, Lund G. Magnetic resonance imaging in Valvular heart disease: clinical application and current role for patient management. J Magn Reson Imaging. 2012;35:1241–52. https://doi.org/10.1002/jmri.23544.CrossRefPubMed

Griswold MA, Jakob PM, Heidemann RM, , Nittka M, Jellus V, Wang J Nittka M, Jellus V, Wang J, Kiefer B, Haase A Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn Reson Med 2002; 47:1202–1210. DOI: https://doi.org/10.1002/mrm.10171.CrossRefPubMed

Myerson SG. Heart valve disease: investigation by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2012;14:7. https://doi.org/10.1186/1532-429X-14-7.CrossRefPubMedPubMedCentral

Bieri O, Scheffler K. Fundamental of balanced steady state free precession MRI. J Magn Reson Imaging. 2013;38:2–11. https://doi.org/10.1002/jmri.24163.CrossRefPubMed

Van Dijk P. ECG-triggered NMR imaging of the heart. Diagn Imaging Clin Med. 1984;53:29–37.PubMed

10.

Lenz GW, Haacke EM, White RD. Retrospective cardiac gating: a review of technical aspects and future directions. Magn Reson Imaging. 1989;7:445–55.CrossRef

11.

Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E. The Society for Cardiovascular Magnetic Resonance Board of Trustees task force on standardized protocols. Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update. J Cardiovasc Magn Reson. 2013;15:91. https://doi.org/10.1186/1532-429X-15-91.CrossRefPubMedPubMedCentral

12.

Longmore DB, Klipstein RH, Underwood SR, Firmin DN, Hounsfield GN, Watanabe M, et al. Dimensional accuracy of magnetic resonance in studies of the heart. Lancet. 1985;1:1360–2.CrossRef

13.

Dursun M, Yılmaz S, Yılmaz E, Yılmaz R, Onur İ, Oflaz H, et al. The utility of cardiac MRI in diagnosis of infective endocarditis: preliminary results. Diagn Interv Radiol. 2015;21(1):28–33. https://doi.org/10.5152/dir.2014.14239.CrossRefPubMed

14.

Caduff JH, Hernandez RJ, Ludomirsky A. MR visualization of aortic valve vegetations. J Comput Assist Tomogr. 1996;20:613–5.CrossRef

15.

Wagner S, Auffermann W, Buser P, Lim TH, Kircher B, Pflugfelder P, et al. Diagnostic accuracy and estimation of the severity of valvular regurgitation from the signal void on cine magnetic resonance images. Am Heart J. 1989;118:760–7.CrossRef

16.

Sievers B, Brandts B, Franken U, Trappe HJ. Cardiovascular magnetic resonance imaging demonstrates mitral valve endocarditis. Am J Med. 2003;115:681–2.CrossRef

17.

Sechtem U, Pflugfelder PW, Gould RG, Cassidy MM, Higgins CB. Measurement of right and left ventricular volumes in healthy individuals with cine MR imaging. Radiology. 1987;163:697–702. https://doi.org/10.1148/radiology.163.3.3575717.CrossRefPubMed

18.

Katz J, Whang J, Boxt LM, Barst RJ. Estimation of right ventricular mass in normal subjects and in patients with pulmonary hypertension by magnetic resonance imaging. J Am Coll Cardiol. 1993;21:1475–81.CrossRef

19.

Clarke CJ, Gurka MJ, Norton PT, Kramer CM, Hoyer AW. Assessment of the accuracy and reproducibility of RV volume measurements by CMR in congenital heart disease. J Am Coll Cardiol Img. 2012;5:28–37. https://doi.org/10.1016/j.jcmg.2011.05.007.CrossRef

20.

Alfakih K, Plein S, Bloomer T, Jones T, Ridgeway J, Sivananthan M. Comparison of right ventricular volume measurements between axial and short axis orientation using steady-state free precession magnetic resonance imaging. J Magn Reson Imaging. 2003;18:25–32. https://doi.org/10.1002/jmri.10329.CrossRefPubMed

21.

Evans AJ, Blinder RA, Herfkens RJ, Spritzer CE, Kuethe DO, Fram EK, et al. Effects of turbulence on signal intensity in gradient echo images. Investig Radiol. 1988;23:512–8.CrossRef

22.

Malayeri AA, Johnson WC, Macedo R, Bathon J, Lima JA, Bluemke DA. Cardiac cine MRI: quantification of the relationship between fast gradient echo and steady-state free precession for determination of myocardial mass and volumes. J Magn Reson Imaging. 2008;28:60–6. https://doi.org/10.1002/jmri.21405.CrossRefPubMedPubMedCentral

23.

Aurigemma G, Reichek N, Schiebler M, Axel L. Evaluation of aortic regurgitation by cardiac cine magnetic resonance imaging: planar analysis and comparison to Doppler echocardiography. Cardiology. 1991;78(4):340–7. https://doi.org/10.1159/000174815.CrossRefPubMed

24.

Ozdogan O, Yuksel A, Gurgun C, Kayikcioglu M, Yavuzgil O, Cinar CS. Evaluation of the severity of mitral regurgitation by the use of signal void in magnetic resonance imaging. Echocardiography. 2009;26(10):1127–35. https://doi.org/10.1111/j.1540-8175.2009.00968.x.CrossRefPubMed

25.

Spielmann RP, Schneider O, Thiele F, Heller M, Bucheler E. Appearance of poststenotic jets in MRI: dependence on flow velocity and on imaging parameters. Magn Reson Imaging. 1991;9:67–72.CrossRef

26.

Sondergaard L, Stahlberg F, Thomsen C. Magnetic resonance imaging of valvular heart disease. J Magn Reson Imaging. 1999;10:627–38.CrossRef

27.

Utz JA, Herfkens RJ, Heinsimer JA, Shimakawa A, Glover G, Pelc N. Valvular regurgitation: dynamic MR imaging. Radiology. 1988;168:91–4.CrossRef

28.

Mitchell L, Jenkins JPR, Watson Y, Rowlands DJ, Isherwood I. Diagnosis and assessment of mitral and aortic valve disease by cine-flow magnetic resonance imaging. Magn Reson Med. 1989;12:181–97.CrossRef

29.

Cawley PJ, Maki JH, Otton CM. Cardiovascular magnetic resonance imaging for Valvular heart disease technique and validation. Circulation. 2009;119:468–78. https://doi.org/10.1161/CIRCULATIONAHA.107.742486.CrossRefPubMed

30.

Underwood SR, Firmin DN, Rees RS, Longmore DB. Magnetic resonance velocity mapping. Clin Phys Physiol Meas. 1990;11(Suppl A):37–43.CrossRef

31.

Pelc NJ, Herfkens RJ, Shimakawa A, Enzmann DR. Phase contrast cine magnetic resonance imaging. Magn Reson Q. 1991;7:229–54.PubMed

32.

Kilner PJ, Gatehouse PD, Firmin DN. Flow measurement by magnetic resonance: a unique asset worth optimising. J Cardiovasc Magn Reson. 2007;9:723–8. https://doi.org/10.1080/10976640701465090.CrossRefPubMed

33.

Gatehouse PD, Keegan J, Crowe LA, Masood S, Mohiaddin RH, Kreitner KF, et al. Applications of phase-contrast flow and velocity imaging in cardiovascular MRI. Eur Radiol. 2005;15:2172–84. https://doi.org/10.1007/s00330-005-2829-3.CrossRefPubMed

34.

Firmin DN, Nayler GL, Kilner PJ, Longmore DB. The application of phase shifts in NMR for flow measurement. Magn Reson Med. 1990;14:230–41.CrossRef

35.

Gatehouse PD, Rolf MP, Graves MJ, Hofman MB, Totman J, Werner B, et al. Flow measurement by cardiovascular magnetic resonance: a multi-centre multi-vendor study of background phase offset errors that can compromise the accuracy of derived regurgitant or shunt flow measurements. J Cardiovasc MagnReson. 2010;12:5. https://doi.org/10.1186/1532-429X-12-5.CrossRef

36.

O’Brien KR, Cowan BR, Jain M, Stewart RA, Kerr AJ, Young AA. MRI phase contrast velocity and flow errors in turbulent stenotic jets. J Magn Reson Imaging. 2008;28:210–8. https://doi.org/10.1002/jmri.21395.CrossRefPubMed

37.

Hundley WG, Li HF, Hillis LD, Meshack BM, Lange RA, Willard JE, et al. Quantitation of cardiac output with velocity-encoded, phase-difference magnetic resonance imaging. Am J Cardiol. 1995;75:1250–5.CrossRef

38.

Sondergaard L, Thomsen C, Stahlberg F, Gymoese E, Lindvig K, Hildebrandt P, et al. Mitral and aortic valvular flow: quantification with MR phase mapping. J Magn Reson Imaging. 1992;2:295–302.CrossRef

39.

Mor-Avi V, Jenkins C, Kuhl HP, Nesser HJ, Marwick T, Franke A, et al. Real-time 3-dimensional echocardiographic quantification of left ventricular volumes Multicenter Study for Validation With Magnetic Resonance Imaging and Investigation of Sources of Error. JACC Img. 2008;1(4):413–23. https://doi.org/10.1016/j.jcmg.2008.02.009.CrossRef

40.

Myerson SG, d'Arcy J, Mohiaddin R, Greenwood JP, Karamitsos TD, Francis JM, et al. Aortic regurgitation quantification using cardiovascular magnetic resonance association with clinical outcome. Circulation. 2012;126:1452–60. https://doi.org/10.1161/CIRCULATIONAHA.111.083600.CrossRefPubMed

41.

Chatzimavroudis GP, Walter PG, Oshinski JN, Franch RH, Pettigrew RI, Yoganathan AP. Slice location dependence of aortic regurgitation measurements with MR phase velocity mapping. Mag Reson Med. 1997;37:545–51.CrossRef

42.

Cawley PJ, Hamilton-Crai C, Owens DS, Krieger EV, Strugnell WE, Mitsumori L, et al. Prospective comparison of valve regurgitation quantitation by cardiac magnetic resonance imaging and transthoracic echocardiography. Circ Cardiovasc Imaging. 2013;6:48–57. https://doi.org/10.1161/CIRCIMAGING.112.975623.CrossRefPubMed

43.

Fratz S, Chung T, Greil GF, Samyn MM, Taylor AM, Valsangiacomo Buechel ER, et al. Guidelines and protocols for cardiovascular magnetic resonance in children and adults with congenital heart disease: SCMR expert consensus group on congenital heart disease. J Cardiovasc Magn Reson. 2013 Jun 13;15:51. https://doi.org/10.1186/1532-429X-15-51.CrossRefPubMedPubMedCentral

44.

Chatzimavroudis GP, Oshinski JN, Franch RH, Walker PG, Yoganathan AP, Pettigrew RI. Evaluation of the precision of magnetic resonance phase velocity mapping for blood flow measurements. J Cardio Mag Reson. 2001;3(1):11–9.CrossRef

45.

Schulz-Menger J, Bluemke DA, Bremerich J, Flamm SD, Fogel MA, Friedrich MG, et al. Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson. 2013;15:35. https://doi.org/10.1186/1532-429X-15-35.CrossRefPubMedPubMedCentral

46.

Iwamoto Y, Inage A, Tomlinson G, Lee KJ, Grosse-Wortmann L, Seed M, et al. Direct measurement of aortic regurgitation with phase-contrast magnetic resonance is inaccurate: proposal of an alternative method of quantification. Pediatr Radiol. 2014;44(11):1358–69. https://doi.org/10.1007/s00247-014-3017-x.CrossRefPubMed

47.

Gelfand EV, Hughes S, Hauser TH, Yeon SB, Goepfert L, Kissinger KV. Severity of mitral and aortic regurgitation as assessed by cardiovascular magnetic resonance: optimizing correlation with Doppler echocardiography. J Cardiovasc Magn Reson. 2006;8(3):503–7.CrossRef

48.

Topilsky Y, Michelena H, Bichara V, Maalouf J, Mahoney DW, Enriquez-Sarano M, et al. Mitral valve prolapse with mid-late systolic mitral regurgitation: pitfalls of evaluation and clinical outcome compared with holosystolic regurgitation. Circulation. 2012;125(13):1643–51. https://doi.org/10.1161/CIRCULATIONAHA.111.055111.CrossRefPubMed

49.

•• Uretsky S, Argulian E, Narula J, Wolff SD. Use of cardiac magnetic resonance imaging in assessing mitral regurgitation: current evidence. J Am Coll Cardiol. 2018;71(5):547–63. https://doi.org/10.1016/j.jacc.2017.12.009. One of the most recent review articles published describing the utility of CMR in the evaluation of mitral regurgitation, including a proposed clinical pathway and guidelines. CrossRefPubMed

50.

Hundley WG, Li HF, Willard JE, Landau C, Lange RA, Meshack BM, et al. Magnetic resonance imaging assessment of the severity of mitral regurgitation. Comparison with invasive techniques. Circulation. 1995;92(5):1151–8.CrossRef

51.

Myerson SG, d'Arcy J, Christiansen JP, Dobson LE, Mohiaddin R, Francis JM, et al. Determination of clinical outcome in mitral regurgitation with cardiovascular magnetic resonance quantification. Circulation. 2016;133(23):2287–96. https://doi.org/10.1161/CIRCULATIONAHA.115.017888.CrossRefPubMed

52.

Dujardin KS, Enriquez-Sarano M, Bailey KR, Nishimura RA, Seward JB, Tajik AJ. Grading of mitral regurgitation by quantitative Doppler echocardiography: calibration by left ventricular angiography in routine clinical practice. Circulation. 1997;96(10):3409–15.CrossRef

53.

Lopez-Mattei JC, Ibrahim H, Shaikh KA, Little SH, Shah DJ, Maragiannis D, et al. Comparative assessment of mitral regurgitation severity by transthoracic echocardiography and cardiac magnetic resonance using an integrative and quantitative approach. Am J Cardiol. 2016;117(2):264–70. https://doi.org/10.1016/j.amjcard.2015.10.045.CrossRefPubMed

54.

Uretsky S, Gillam L, Lang R, Chaudhry FA, Argulian E, Supariwala A, et al. Discordance between echocardiography and MRI in the assessment of mitral regurgitation severity: a prospective multicenter trial. J Am Coll Cardiol. 2015;65(11):1078–88. https://doi.org/10.1016/j.jacc.2014.12.047.CrossRefPubMed

55.

• Penicka M, Vecera J, Mirica DC, Kotrc M, Kockova R, Van Camp G. Prognostic implications of magnetic resonance-derived quantification in asymptomatic patients with organic mitral regurgitation: comparison with doppler echocardiography-derived integrative approach. Circulation. 2018;137(13):1349–60. https://doi.org/10.1161/CIRCULATIONAHA.117.029332. One of the few studies detailing the prognostic implications of CMR use in evaluating MR in asymptomatic individuals. CrossRefPubMed

56.

Choi J, Heo R, Hong GR, Chang HJ, Sung JM, Shin SH, et al. Differential impact of three-dimensional color Doppler echocardiography for the quantification of mitral regurgitation according to the severity and characteristics. Circ Cardiovasc Imaging. 2014;7(3):535–44. https://doi.org/10.1161/CIRCIMAGING.113.001457.CrossRefPubMed

57.

Thavendiranathan P, Liu S, Datta S, Rajagopalan S, Ryan T, Igo SR, et al. Quantification of chronic functional mitral regurgitation by automated 3-dimensional peak and integrated proximal isovelocity surface area and stroke volume techniques using real-time 3-dimensional volume color Doppler echocardiography: in vitro and clinical validation. Circ Cardiovasc Imaging. 2013;6(1):125–33. https://doi.org/10.1161/CIRCIMAGING.112.980383.CrossRefPubMed

58.

Mercer-Rosa L, Yang W, Rychik J, Fogel M, Goldmuntz E. Quantifying pulmonary regurgitation and right ventricular function in surgically repaired tetralogy of Fallot a comparative analysis of echocardiography and magnetic resonance imaging. Circ Cardiovasc Imaging. 2012;5:637–43. https://doi.org/10.1161/CIRCIMAGING.112.972588.CrossRefPubMedPubMedCentral

59.

Medvedofsky D, Mor-Avi V, Kruse E, Guile B, Ciszek B, Weinert L, et al. Quantification of right ventricular size and function from contrast-enhanced three-dimensional echocardiographic images. J Am Soc Echocardiogry. 2017;30(12):1193–202. https://doi.org/10.1016/j.echo.2017.08.003.CrossRef

60.

Saremi F, Gera A, Ho SY, Hijazi ZM, Sánchez-Quintana D. CT and MR imaging of the pulmonary valve. Radiographics. 2014 Jan-Feb;34(1):51–71. https://doi.org/10.1148/rg.341135026.CrossRefPubMed

61.

Li W, Davlouros PA, Kilner PJ, Pennell DJ, Gibson D, Henein MY, et al. Doppler-echocardiographic assessment of pulmonary regurgitation in adults with repaired tetralogy of Fallot: comparison with cardiovascular magnetic resonance imaging. Am Heart J. 2004;147:165–72.CrossRef

62.

Rebergen SA, Chin JG, Ottenkamp J, van der Wall EE, de Roos A. Pulmonary regurgitation in the late postoperative follow-up of tetralogy of Fallot. Volumetric quantitation by nuclear magnetic resonance velocity mapping. Circulation. 1993;88:2257–66.CrossRef

63.

Vliegen HW, van Straten A, de Roos A, Roest AA, Schoof PH, Zwinderman AH, et al. Magnetic resonance imaging to assess the hemodynamic effects of pulmonary valve replacement in adults late after repair of tetralogy of fallot. Circulation. 2002;106:1703–7.CrossRef

64.

Therrien J, Provost Y, Merchant N, Williams W, Colman J, Webb G. Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol. 2005;95:779–82.CrossRef

65.

Henkens IR, van Straten A, Schalij MJ, Hazekamp MG, Roos d, van der Wall EE, et al. Predicting outcome of pulmonary valve replacement in adult tetralogy of Fallot patients. Ann Thorac Surg. 2007;83:907–11.CrossRef

66.

Oosterhof T, van Straten A, Vliegen HW, Meijboom FJ, van Dijk AP, Spijkerboer AM, et al. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation. 2007 Jul 31;116(5):545–51. https://doi.org/10.1161/CIRCULATIONAHA.106.659664.CrossRefPubMed

67.

Jun H, Park EA, Bahn YE, Lee W, Kim HK, Chung JW. Quantification of tricuspid regurgitation using two-dimensional velocity encoding cine: optimal plane and reproducibility. Int J Cardiovasc Imaging. 2015;31(2):233–40. https://doi.org/10.1007/s10554-015-0715-x.CrossRefPubMed

68.

Westenberg JJ, Roes SD, Ajmone Marsan N, Binnendijk NM, Doornbos J, Bax JJ, et al. Mitral valve and tricuspid valve blood flow: accurate quantification with 3D velocity-encoded MR imaging with retrospective valve tracking. Radiology. 2008;249(3):792–800. https://doi.org/10.1148/radiol.2492080146.CrossRefPubMed

69.

Moghari MH, Komarlu R, Annese D, Geva T, Powell AJ. Free-breathing steady-state free precession cine cardiac magnetic resonance with respiratory navigator gating. Magn Reson Med. 2015;73(4):1555–61. https://doi.org/10.1002/mrm.25275.CrossRefPubMed

70.

Geiger J, Rahsepar AA, Suwa K, Powell A, Ghasemiesfe A, Barker AJ, et al. 4D flow MRI, cardiac function, and T1-mapping: association of valve-mediated changes in aortic hemodynamics with left ventricular remodeling. J Magn Reson Imaging J Magn Reson Imaging. 2018;48(1):121–31. https://doi.org/10.1002/jmri.25916.CrossRefPubMed

71.

Podlesnikar T, Delgado V, Bax JJ. Cardiovascular magnetic resonance imaging to assess myocardial fibrosis in valvular heart disease. Int J Cardiovasc Imaging. 2018 Jan;34(1):97–112. https://doi.org/10.1007/s10554-017-1195-y.CrossRefPubMed

72.

Auger DA, Zhong X, Epstein FH, Spottiswoode BS. Mapping right ventricular myocardial mechanics using 3D cine DENSE cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2012;14:4. https://doi.org/10.1186/1532-429X-14-4.CrossRefPubMedPubMedCentral

73.

Zorach B, Shaw PW, Bourque J, Kuruvilla S, Balfour PC Jr, Yang Y, et al. Quantitative cardiovascular magnetic resonance perfusion imaging identifies reduced flow reserve in microvascular coronary artery disease. J Cardiovasc Magn Reson. 2018;20(1):14. https://doi.org/10.1186/s12968-018-0435-1.CrossRefPubMedPubMedCentral

74.

Wigstrom L, Sjoqvist L, Wranne B. Temporally resolved 3D phase-contrast imaging. Magn Reson Med. 1996;36:800–3.CrossRef

75.

Pelc NJ, Bernstein MA, Shimakawa A, Glover GH. Encoding strategies for three-direction phase-contrast MR imaging of flow. J Magn Reson Imaging. 1991;1:405–13.CrossRef

76.

Napel S, Lee DH, Frayne R, Rutt BK. Visualizing three-dimensional flow with simulated streamlines and three-dimensional phase-contrast MR imaging. J Magn Reson Imaging. 1992;2:143–53.CrossRef

77.

Kozerke S, Hasenkam JM, Pedersen EM, Boesiger P. Visualization of flow patterns distal to aortic valve prostheses in humans using a fast approach for cine 3D velocity mapping. J Magn Reson Imaging. 2001;13(5):690–8.CrossRef

78.

Brix L, Ringgaard S, Rasmusson A, Sørensen TS, Kim WY. Three dimensional three component whole heart cardiovascular magnetic resonance velocity mapping: comparison of flow measurements from 3D and 2D acquisitions. J Cardiovasc Magn Reson. 2009;11:3. https://doi.org/10.1186/1532-429X-11-3.CrossRefPubMedPubMedCentral

79.

Nordmeyer S, Riesenkampff E, Crelier G, Khasheei A, Schnackenburg B, Berger F, et al. Flow-sensitive four-dimensional cine magnetic resonance imaging for offline blood flow quantification in multiple vessels: a validation study. J Magn Reson Imaging. 2010;32:677–83. https://doi.org/10.1002/jmri.22280.CrossRefPubMed

80.

Nordmeyer S, Riesenkampff E, Messroghli D, Kropf S, Nordmeyer J, Berger F, et al. Four-dimensional velocity-encoded magnetic resonance imaging improves blood flow quantification in patients with complex accelerated flow. J Magn Reson Imaging. 2013;37(1):208–16. https://doi.org/10.1002/jmri.23793.CrossRefPubMed

Title: Role of Cardiac Magnetic Resonance Imaging in Valvular Heart Disease: Diagnosis, Assessment, and Management
Authors: Roshin C. Mathew
Adrián I. Löffler
Michael Salerno
Publication date: 01-11-2018
Publisher: Springer US
Published in: Current Cardiology Reports / Issue 11/2018
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI: https://doi.org/10.1007/s11886-018-1057-9

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Role of Cardiac Magnetic Resonance Imaging in Valvular Heart Disease: Diagnosis, Assessment, and Management

Abstract

Purpose of Review

Recent Findings

Summary

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 11/2018

Is There Still a Role for Digoxin in the Management of Atrial Fibrillation?

His-Bundle Pacing and LV Endocardial Pacing as Alternatives to Traditional Cardiac Resynchronization Therapy

Pulmonary Embolism for the Cardiologist: Emphasis on Diagnosis

Correction to: Update on Devices for Diastolic Dysfunction: Options for a No Option Condition?

Tumor Necrosis Factor-α in Heart Failure: an Updated Review

Transcatheter Mitral Valve Therapy: Defining the Patient Who Will Benefit

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page